Application of Solid Dispersion Technology to Obtain a Model of Injectable Dosage Form of Indolocarbazole Derivative
Introduction. N. N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of Russia synthesized an original derivative of indolocarbazole with the carbohydrate residue xylose, which has a pronounced cytotoxic and anti-angiogenic activity. The substance LCS-1269 is an amorpho...
Main Authors: | A. P. Kolpaksidi, M. V. Dmitrieva, O. L. Orlova, L. V. Ektova, I. I. Krasniuk |
---|---|
Format: | Article |
Language: | Russian |
Published: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2022-11-01
|
Series: | Разработка и регистрация лекарственных средств |
Subjects: | |
Online Access: | https://www.pharmjournal.ru/jour/article/view/1360 |
Similar Items
-
Molecular Mechanisms of Anticancer Activity of N-Glycosides of Indolocarbazoles LCS-1208 and LCS-1269
by: Roman G. Zenkov, et al.
Published: (2021-12-01) -
Obtaining a Water-soluble Form of Hydrophobic Indolelocarbazole Derivative Using Solubilizer Complex
by: A. P. Kolpaksidi, et al.
Published: (2023-02-01) -
Development of a Liposomal Dosage Form Based on Hydrophobic Derivative of Indolocarbazole
by: B. Lugen, et al.
Published: (2020-08-01) -
ANTITUMOR DRUGS BASED ON INDOLOCARBAZOL DERIVATIVES
by: I. P. Kolpaksidi, et al.
Published: (2021-09-01) -
N-Glycoside of Indolo[2,3-<i>a</i>]pyrrolo[3,4-<i>c</i>]carbazole LCS1269 Exerts Anti-Glioblastoma Effects by G2 Cell Cycle Arrest and CDK1 Activity Modulation: Molecular Docking Studies, Biological Investigations, and ADMET Prediction
by: Nikolay Kalitin, et al.
Published: (2024-12-01)